Trials / Terminated
TerminatedNCT05492448
Probiotic on Type 2 Diabetes and Chronic Obstruction Pulmonary Disease
A Randomized Double-Blind Controlled Study Comparing the Effects of Probiotic Adjuvant Therapy on the Improvement of Lung Function and Blood Sugar in Patients With Type 2 Diabetes and Chronic Obstruction Pulmonary Disease
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Glac Biotech Co., Ltd · Industry
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This trial is a randomized, double-blind, parallel placebo clinical trial, the purpose of which is to investigate whether the adjuvant therapy of using probiotics during the treatment of diabetic patients can decrease blood sugar levels significantly in comparison with placebo, and observe if the reduced lung function could be recovered in patients with type 2 diabetes (T2DM) and chronic obstructive pulmonary disease (COPD) simultaneously.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | Subjects take one pack containing maltodextrin twice daily after breakfast and dinner. |
| DIETARY_SUPPLEMENT | L. salivarius AP-32 and L. reuteri GL-104 | Subjects take one pack containing L. salivarius AP-32 and L. reuteri GL-104 twice daily after breakfast and dinner. |
| DIETARY_SUPPLEMENT | L. reuteri GL-104 | Subjects take one pack containing L. reuteri GL-104 twice daily after breakfast and dinner. |
Timeline
- Start date
- 2022-09-19
- Primary completion
- 2025-08-15
- Completion
- 2025-12-31
- First posted
- 2022-08-08
- Last updated
- 2026-02-27
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05492448. Inclusion in this directory is not an endorsement.